Teva Pharmaceutical Industries Ltd
TEVA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818686
In the last 90 days, Teva Pharmaceutical Industries Ltd insiders filed 0 open-market purchases and 8 sales; 675 institutions reported holding it in 13F filings for Q2 2026, worth $24.7B in total; 3 superinvestors hold it, including Greenlight Capital and Duquesne Family Office.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Teva Pharmaceutical Industries Ltd insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 8 filings
- 8 insiders, $17.0M in total
- Insiders trading
- 8
- Net value
- −$17.0M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Teva Pharmaceutical Industries Ltd, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Savage Brian | Interim Chief Legal Officer | 8,500 | Sep 22, 2026 | 4 |
| Mignone Roberto | Director | 0Indirect | Sep 22, 2026 | 6 |
| Weiss Amir | Chief Accounting Officer | 13,071 | Aug 25, 2026 | 7 |
| Satchi-Fainaro Ronit | Director | 111,986 | Aug 25, 2026 | 3 |
| Lippman Evan | EVP, Business Development | 25,591 | Aug 19, 2026 | 3 |
| Zaks Tal Zvi | Director | 73,247 | Aug 10, 2026 | 3 |
| Jover Placid | See "Remarks" | 6,774 | Aug 5, 2026 | 3 |
| Hughes Eric A | See "Remarks" | 134,877 | Aug 5, 2026 | 5 |
| Shields Matthew | EVP, Global Operations | 0 | Jun 22, 2026 | 4 |
| Kalif Eliyahu Sharon | EVP, Chief Financial Officer | 65,621 | Jun 16, 2026 | 7 |
| Lieberman Gerald M | Director | 130,149 | Jun 8, 2026 | 2 |
| Barer Sol J | Director | 448,011 | Jun 8, 2026 | 2 |
| Crane Rosemary A | Director | 127,739 | Jun 8, 2026 | 2 |
| Francis Richard D | President and CEO | 1,177,529 | Jun 8, 2026 | 6 |
| Nisen Perry | Director | 119,807 | Jun 8, 2026 | 2 |
| Elstein Amir | Director | 2,118,455 | Jun 8, 2026 | 2 |
| Lichtenstein Chen | Director | 19,296 | Jun 8, 2026 | 3 |
| Daniell Richard | EVP, Europe Commercial | 55,755 | May 7, 2026 | 6 |
| Sabag Mark | See "Remarks" | 80,760 | May 4, 2026 | 7 |
| Fox Christine | EVP, U.S. Commercial | 63,647 | May 4, 2026 | 5 |
| McAvoy David R. | EVP, Chief Legal Officer | 13,027 | Sep 9, 2025 | 0 |
| Vergis Janet S. | Director | 73,697 | Jun 9, 2025 | 0 |
| Shalev Varda | Director | 22,504 | Jun 9, 2025 | 0 |
| Grant Angus | EVP, Business Development | 8,848 | Aug 13, 2024 | 0 |
| Conway Vikki L | See "Remarks" | 0 | May 15, 2024 | 0 |
| Drape Eric | Executive VP Global Operations | 145,915 | Mar 7, 2024 | 0 |
| Bergwerk Dov | Acting Chief Legal Officer | 96,983 | Mar 1, 2024 | 0 |
| Stark David Matthew | Exec. VP Chief Legal Officer | 2,974 | Mar 8, 2023 | 0 |
| Dethlefs Sven | EVP, North America Commercial | 165,381 | Mar 8, 2023 | 0 |
| Shani Eli | EVP,Global Marketing&Portfolio | 54,228 | Mar 7, 2023 | 0 |
| Inbar Galia | See "Remarks" | 46,011 | Mar 7, 2023 | 0 |
| Schultz Kare | President and CEO | 1,542,471 | Nov 2, 2022 | 0 |
| Halfon Jean Michel | Director | 63,707 | Aug 8, 2022 | 0 |
| Peres Nechemia Jacob | Director | 58,765 | Aug 8, 2022 | 0 |
| Fridriksdottir Hafrun | Executive VP, Global R&D | 1,387 | May 19, 2022 | 0 |
| Weil Andrew | Chief Accounting Officer | – | Nov 4, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 (view filing) | Apr 30 | 4 days | Fox ChristineEVP, U.S. Commercial | SSale | −21.3K | $35.31 | −$750.6K | −25.0%63.6K after | |
| May 4, 2026 (view filing) | May 1 | 3 days | Sabag MarkSee "Remarks" | SSale | −144.2K | $34.99 | −$5.04M | −64.1%80.8K after | |
| May 7, 2026 (view filing) | May 5 | 2 days | Daniell RichardEVP, Europe Commercial | SSale | −30.0K | $35.40 | −$1.06M | −35.0%55.8K after | |
| May 7, 2026 (view filing) | May 6 | 1 day | Weiss AmirChief Accounting Officer | SSale | −10.7K | $36.00 | −$384.4K | −34.8%20.0K after | |
| May 18, 2026 (view filing) | May 14 | 4 days | Kalif Eliyahu SharonEVP, Chief Financial Officer | SSale | −153.3K | $35.61 | −$5.46M | −47.1%172.2K after | 10b5-1 |
| May 18, 2026 (view filing) | May 14 | 4 days | Lippman EvanEVP, Business Development | SSale | −41.7K | $35.58 | −$1.48M | −48.5%44.2K after | 2 lots10b5-1 |
| Jun 4, 2026 (view filing) | Jun 3 | 1 day | Shields MatthewEVP, Global Operations | SSale | −16.2K | $32.87 | −$532.3K | −61.9%9.99K after | 10b5-1 |
| Jun 8, 2026 (view filing) | Jun 5 | 3 days | Francis Richard DPresident and CEO | SSale | −6.15K | $34.35 | −$211.4K | −0.5%1.18M after | 10b5-1 |
| Jun 16, 2026 (view filing) | Jun 11 | 5 daysLate | Kalif Eliyahu SharonEVP, Chief Financial Officer | SSale | −106.6K | $34.10 | −$3.63M | −61.9%65.6K after | 10b5-1 |
| Jun 22, 2026 (view filing) | Jun 18 | 4 days | Shields MatthewEVP, Global Operations | SSale | −9.99K | $32.19 | −$321.5K | −100.0%0 after | |
| Aug 5, 2026 (view filing)4:02 PM ET | Aug 3 | 2 days | Hughes Eric ASee "Remarks" | SSale | −25.6K | $34.88 | −$892.1K | −15.9%134.9K after | 10b5-1 |
| Aug 5, 2026 (view filing)4:04 PM ET | Aug 3 | 2 days | Jover PlacidSee "Remarks" | SSale | −12.8K | $34.88 | −$447.4K | −65.4%6.77K after | 10b5-1 |
| Aug 10, 2026 (view filing)6:07 AM ET | Aug 5 | 5 daysLate | Zaks Tal ZviDirector | SSale | −17 | $34.87 | −$592.71 | 0.0%73.2K after | |
| Aug 19, 2026 (view filing)4:00 PM ET | Aug 17 | 2 days | Lippman EvanEVP, Business Development | SSale | −18.6K | $36.57 | −$680.3K | −42.1%25.6K after | 10b5-1 |
| Aug 25, 2026 (view filing)4:03 PM ET | Aug 21 | 4 days | Satchi-Fainaro RonitDirector | SSale | −415 | $37.25 | −$15.5K | −0.4%112.0K after | |
| Aug 25, 2026 (view filing)4:05 PM ET | Aug 21 | 4 days | Weiss AmirChief Accounting Officer | SSale | −9.45K | $37.62 | −$355.3K | −41.9%13.1K after | 2 lots |
| Sep 22, 2026 (view filing)4:21 PM ET | Sep 18 | 4 days | Mignone RobertoDirector | SSale | −367.6K | $39.06 | −$14.4M | −100.0%0 after | |
| Sep 22, 2026 (view filing)5:01 PM ET | Sep 18 | 4 days | Savage BrianInterim Chief Legal Officer | SSale | −7.34K | $38.85 | −$285.2K | −46.3%8.50K after | 3 lots |